|
| 三元生物(301206)限售解禁 | | 解禁日期 | 本期流通股本
(万股) | 本期流通股本占
总股本比例(%) | 已流通股本
(万股) | 未流通股本
(万股) | 流通A股
(万股) | 流通A股占
总股本比例(%) | 限售股类型 | | 2025-08-11 | 9294.60 | 45.94% | 19785.58 | 446.99 | 10354.48 | 51.18% | 首发原股东限售股份 | | 2025-02-10 | 136.50 | 0.67% | 10490.98 | 9741.59 | 10343.93 | 51.13% | 首发原股东限售股份 | | 2023-08-10 | 134.70 | 0.67% | 10343.93 | 9888.64 | 10209.23 | 50.46% | 首发原股东限售股份 | | 2023-02-10 | 5151.08 | 25.46% | 10209.23 | 10023.34 | 10209.23 | 50.46% | 首发原股东限售股份 | | 2022-08-15 | 260.92 | 1.29% | 5058.15 | 15174.42 | 5058.15 | 25.00% | 首发机构配售股份 | | 2022-02-10 | 3198.15 | 23.71% | 3198.15 | 10290.23 | 3198.15 | 23.71% | 首发一般股份 |
|